CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CYTK — Cytokinetics Inc
CIK 884546
SAN FRANCISCO, CA
Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$133,388,883
+$41,309,648 QoQ
Shares Held
1,565,781
+12.1% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#21
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CYTK ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
This page
|
1,565,781 | $133,388,883 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,388,883 | 1,565,781 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $92,079,235 | 1,397,045 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $87,903,586 | 1,383,437 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $75,508,609 | 1,373,883 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $44,839,145 | 1,357,117 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $52,763,722 | 1,312,857 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $62,807,290 | 1,335,189 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $69,769,444 | 1,321,391 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $50,153,450 | 925,682 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $54,374,231 | 775,556 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $65,954,511 | 789,969 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $22,292,735 | 756,712 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $25,152,564 | 771,078 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $25,431,144 | 722,681 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $33,269,077 | 726,082 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,167,521 | 705,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,848,833 | 606,995 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,104,110 | 600,492 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $26,649,076 | 584,666 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $21,856,189 | 611,533 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $10,118,706 | 511,304 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,014,051 | 473,519 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,521,021 | 458,182 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,717,624 | 448,851 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,166,113 | 388,889 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $4,333,237 | 367,535 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||